OncoCyte Corp (OCX)
2.21
0.00 (0.00%)
USD |
NASDAQ |
Dec 20, 16:00
2.23
+0.02
(+0.90%)
After-Hours: 20:00
OncoCyte Profit Margin (Quarterly): -11.73K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Fonar Corp | 12.56% |
| XWELL Inc | -56.40% |
| ProPhase Labs Inc | -209.4% |
| Applied DNA Sciences Inc | -405.5% |
| Veracyte Inc | 13.08% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -211.4% |
| Return on Assets | -57.93% |
| Return on Invested Capital | -211.4% |
| Gross Profit Margin (Quarterly) | 43.48% |
| Operating Margin (Quarterly) | -5.54K% |
| Return on Net Operating Assets | -68.41% |